Los Angeles Capital Management LLC Praxis Precision Medicines, Inc. Transaction History

Los Angeles Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 04, 2023	BUY	$0.8 - $4.98 $105,238 - $655,109	131,548 Added 99.41%	263,873 $213,000
Q4 2022 Feb 06, 2023	BUY	$1.88 - $2.49 $49,274 - $65,262	26,210 Added 24.7%	132,325 $314,000
Q3 2022 Nov 02, 2022	SELL	$2.5 - $4.77 $3,325 - $6,344	-1,330 Reduced 1.24%	106,115 $241,000
Q2 2022 Aug 05, 2022	BUY	$1.75 - $11.34 $157,228 - $1.02 Million	89,845 Added 510.48%	107,445 $263,000
Q2 2021 Aug 05, 2021	SELL	$18.28 - $33.05 $15,172 - $27,431	-830 Reduced 4.5%	17,600 $322,000

Q1 2021 May 05, 2021	BUY	$29.34 - $60.2 $540,736 - $1.11 Million	18,430 New	18,430 $603,000

75K

Ticker PRAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,576,100
Market Cap $1.84B
Description
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of ...

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Los Angeles Capital Management LLC with notifications on news.